Federated Hermes Inc. Acquires Shares of 38,389 PetMed Express, Inc. (NASDAQ:PETS)

Federated Hermes Inc. bought a new position in shares of PetMed Express, Inc. (NASDAQ:PETS) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 38,389 shares of the company’s stock, valued at approximately $290,000. Federated Hermes Inc. owned approximately 0.18% of PetMed Express at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of PetMed Express by 5.6% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 737,547 shares of the company’s stock worth $7,560,000 after purchasing an additional 38,894 shares in the last quarter. Profit Investment Management LLC boosted its stake in shares of PetMed Express by 19.3% during the 4th quarter. Profit Investment Management LLC now owns 182,333 shares of the company’s stock worth $1,378,000 after acquiring an additional 29,438 shares in the last quarter. Ancora Advisors LLC purchased a new position in PetMed Express in the 3rd quarter valued at approximately $958,000. Trexquant Investment LP purchased a new stake in PetMed Express during the third quarter worth $554,000. Finally, Quadrature Capital Ltd increased its position in shares of PetMed Express by 127.2% in the third quarter. Quadrature Capital Ltd now owns 29,597 shares of the company’s stock valued at $303,000 after buying an additional 16,573 shares in the last quarter. 73.33% of the stock is owned by institutional investors and hedge funds.

PetMed Express Stock Up 1.8 %

NASDAQ:PETS opened at $4.05 on Friday. PetMed Express, Inc. has a 52-week low of $3.92 and a 52-week high of $16.18. The stock has a fifty day simple moving average of $4.58 and a 200-day simple moving average of $6.28. The company has a market capitalization of $85.66 million, a PE ratio of -10.38 and a beta of 0.73.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, April 15th. The company reported ($0.10) earnings per share (EPS) for the quarter. The company had revenue of $65.32 million during the quarter. PetMed Express had a negative net margin of 2.92% and a negative return on equity of 1.25%. As a group, equities analysts anticipate that PetMed Express, Inc. will post 0.01 earnings per share for the current year.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.